ESC Professional Premium Access

Differential prognosis of patients candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome

Congress Session

About the speaker

Doctor Alberto Cordero

UNIVERSITY HOSPITAL SAN JUAN DE ALICANTE, Sant Joan d'Alacant (Spain)
2 presentations
0 follower

8 more presentations in this session

Clopidogrel monotherapy following dual antiplatelet therapy in patients with acute coronary syndrome post-drug-eluting stent implantation: a systematic review and direct/indirect treatment comparison

Speaker: Professor D. Sibbing (Munich, DE)

Thumbnail

Comparative efficacy and safety of ticagrelor vs. prasugrel in patients undergoing PCI for NSTE-ACS. Results of the prospective ALKK-Registry.

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Thumbnail

Ticagrelor or prasugrel in patients with acute coronary syndrome and prior myocardial infarction

Speaker: Doctor M. Scalamogna (Naples, IT)

Thumbnail

Antithrombotic and proton pump inhibitor co-therapy in patients with atrial fibrillation and stable coronary disease: a post hoc analysis of the AFIRE trial

Speaker: Doctor H. Wada (Izunokuni, JP)

Thumbnail

Clinical significance of time-varying on-treatment platelet reactivity after percutaneous coronary intervention

Speaker: Professor Y. Jeong (Changwon, KR)

Thumbnail

Access the full session

Platelets and more

Speakers: Doctor A. Cordero, Professor D. Sibbing, Professor U. Zeymer, Doctor M. Scalamogna, Doctor H. Wada...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk